Related Experiment Video
Updated: Sep 12, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
The contribution of RBM20 truncating variants to human cardiomyopathy
Insights
Truncating variants in RBM20 (RBM20tvs) contribute to arrhythmogenic dilated cardiomyopathy (DCM) but cause milder disease. These RBM20tvs show reduced lifetime disease penetrance compared to other truncating variants.
Area of Science:
- Cardiovascular Genetics
- Molecular Cardiology
- Genetic Etiology of Cardiomyopathies
Background:
- Dilated cardiomyopathy (DCM) diagnosis increasingly relies on genetic testing.
- Missense variants in RBM20 are known to cause highly penetrant arrhythmogenic DCM.
- The clinical significance of truncating RBM20 variants (RBM20tvs) in DCM remains unclear.
Purpose of the Study:
- To assess the contribution of RBM20tvs to the development of DCM.
- To evaluate the natural history and penetrance of RBM20tvs in an international cohort.
- To compare RBM20tvs DCM with RBM20 missense variants and other truncating variants.
Main Methods:
- Assembled an international cohort of DCM patients with RBM20 variants.
- Utilized genome-first UK Biobank data for analysis.
- Assessed etiologic fraction, natural history, and penetrance of RBM20tvs.
Main Results:
- RBM20tvs had a modest etiologic fraction in arrhythmogenic DCM.
- Patients with RBM20tvs DCM presented later and had less family history of cardiac events compared to RBM20 missense variant carriers.
- No significant difference in major heart failure or arrhythmia events, but reduced lifetime hazard in RBM20tvs DCM.
- Lower incidence of cardiomyopathy, heart failure, or major ventricular arrhythmia in UK Biobank participants with RBM20tvs versus T-box transcription factor T (TTNtvs).
Conclusions:
- RBM20tvs contribute to arrhythmogenic DCM phenotypes.
- RBM20tvs confer milder disease severity and reduced lifetime penetrance compared to RBM20 missense variants.
- Consider potential additive interactions of RBM20tvs with other variants in DCM patients and families.
Background:
Genetic diagnosis has become increasingly important to guide clinical decision making for patients with dilated cardiomyopathy (DCM). Disease-causing (P/LP) missense variants in the gene RBM20 cause a highly penetrant arrhythmogenic dilated cardiomyopathy (DCM), but the role of truncating RBM20 variants ( RBM20tvs ) is unclear.
Objective:
Assess the contribution of RBM20tvs to DCM.
Methods:
We assembled an international cohort of DCM patients with RBM20 variants and used data from the genome-first UK Biobank (UKB) to assess the etiologic fraction, natural history and penetrance of RBM20tvs .
Results:
The etiologic fraction of RBM20tvs in arrhythmogenic DCM was modest (0.53[0.32,0.67], p=7.5×10 -5 ). RBM20tv DCM patients presented to referral centers later in life than RBM20 P/LP DCM patients (53±10 vs. 34±18 years, p=4×10 -3 ), and were less likely to have a family history of sudden cardiac arrest (20% vs. 65%, p= 0.046) or cardiomyopathy (20% vs. 78% p=5.4×10 -3 ). There was no significant difference in age- and sex-adjusted incident major heart failure or arrhythmia events between RBM20tv and RBM20 P/LP DCM patients, though sex-adjusted lifetime hazard was reduced in RBM20tv DCM (HR 0.15[0.03,0.66],p=0.009). In UKB, lifetime incidence of cardiomyopathy, heart failure, or major ventricular arrhythmia diagnosis was lower in participants with RBM20tvs than in those with TTNtvs (HR 0.55 [0.36,0.84], p=5.9×10 -3 ).
Conclusions:
RBM20tvs contribute to arrhythmogenic DCM phenotypes, but confer milder disease severity alone than RBM20 P/LP variants, and reduced lifetime disease penetrance compared to TTNtvs . Their potential for additive interactions with other damaging variants should be considered in DCM patients and families.
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy IV: Restrictive Cardiomyopathy
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
RNA Splicing

